Literature DB >> 23406838

Diagnosis-related groups for stroke in Europe: patient classification and hospital reimbursement in 11 countries.

Mikko Peltola1, Wilm Quentin.   

Abstract

BACKGROUND: Diagnosis-related groups (DRGs) are increasingly being used for various purposes in many countries. However, there are no studies comparing different DRG systems in the care of stroke. As part of the EuroDRG project, researchers from 11 countries (i.e. Austria, England, Estonia, Finland, France, Germany, Ireland, the Netherlands, Poland, Sweden and Spain) compared how their DRG systems deal with stroke patients. The study aims to assist clinicians and national authorities to optimize their DRG systems.
METHODS: National or regional databases were used to identify hospital cases with a diagnosis of stroke. DRG classification algorithms and indicators of resource consumption were compared for those DRGs that individually represent at least 1% of stroke cases. In addition, standardized case vignettes were defined, and quasi prices according to national DRG-based hospital payment systems were ascertained.
RESULTS: European DRG systems vary widely: they classify stroke patients according to different sets of variables (between 1 and 7 classification variables) into diverging numbers of DRGs (between 1 and 10 DRGs). In 6 of the countries more than half of the patients are concentrated within a single DRG. The countries' systems also vary with respect to the evaluation of different kinds of stroke patients. The most complex DRG is considered 3.8 times more resource intensive than an index case in Finland. By contrast, in England, the DRG system does not account for complex cases. Comparisons of quasi prices for the case vignettes show that hypothetical payments for the index case amount to only EUR 907 in Poland but to EUR 7,881 in Ireland.
CONCLUSIONS: Large variations in the classification of stroke patients raise concerns whether all systems rely on the most appropriate classification variables and whether the DRGs adequately reflect differences in the complexity of treating different groups of patients. Learning from other DRG systems may help in improving the national systems. Clinicians and national DRG authorities should consider how other countries' DRG systems classify stroke patients in order to optimize their DRG system and to ensure fair and appropriate reimbursement. In future, quantitative research is needed to verify whether the most important determinants of cost are considered in different patient classification systems, and whether differences between systems reflect country-specific differences in treatment patterns and, most importantly, what influence they have on patient outcomes.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23406838     DOI: 10.1159/000346092

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  10 in total

1.  Heterogeneity of European DRG systems and potentials for a common EuroDRG system Comment on "Cholecystectomy and Diagnosis-Related Groups (DRGs): patient classification and hospital reimbursement in 11 European countries".

Authors:  Alexander Geissler; Wilm Quentin; Reinhard Busse
Journal:  Int J Health Policy Manag       Date:  2015-03-05

2.  High total hospitalization cost but low cost of imaging studies in recurrent acute ischemic stroke patients.

Authors:  Young Dae Kwon; Sung Sang Yoon; Hyejung Chang
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

3.  Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China.

Authors:  Yuesong Pan; Qidong Chen; Xingquan Zhao; Xiaoling Liao; Chunjuan Wang; Wanliang Du; Gaifen Liu; Liping Liu; Chunxue Wang; Yilong Wang; Yongjun Wang
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

4.  Research on diagnosis-related group grouping of inpatient medical expenditure in colorectal cancer patients based on a decision tree model.

Authors:  Suo-Wei Wu; Qi Pan; Tong Chen
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

5.  Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review.

Authors:  Alexander V van Schoonhoven; Judith J Gout-Zwart; Marijke J S de Vries; Antoinette D I van Asselt; Evgeni Dvortsin; Pepijn Vemer; Job F M van Boven; Maarten J Postma
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

6.  Cost Control of Treatment for Cerebrovascular Patients Using a Machine Learning Model in Western China.

Authors:  Siyu Zeng; Li Luo; Yuanchen Fang; Xiaozhou He
Journal:  J Healthc Eng       Date:  2021-11-22       Impact factor: 2.682

7.  Study of Hospitalization Costs in Patients with Cerebral Ischemia Based on E-CHAID Algorithm.

Authors:  Jing Gong; Ying Wang; Siou-Tang Huang; Herng-Chia Chiu
Journal:  J Healthc Eng       Date:  2022-05-02       Impact factor: 3.822

8.  Can competition improve hospital quality of care? A difference-in-differences approach to evaluate the effect of increasing quality transparency on hospital quality.

Authors:  Christoph Strumann; Alexander Geissler; Reinhard Busse; Christoph Pross
Journal:  Eur J Health Econ       Date:  2022-01-08

9.  Acute myocardial infarction and diagnosis-related groups: patient classification and hospital reimbursement in 11 European countries.

Authors:  Wilm Quentin; Hanna Rätto; Mikko Peltola; Reinhard Busse; Unto Häkkinen
Journal:  Eur Heart J       Date:  2013-01-30       Impact factor: 29.983

10.  How Well Do All Patient Refined-Diagnosis-Related Groups Explain Costs of Pediatric Cancer Chemotherapy Admissions in the United States?

Authors:  Heidi Russell; Andrew Street; Vivian Ho
Journal:  J Oncol Pract       Date:  2016-04-26       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.